top of page
BLOG
News, views and analysis
The Evidence-Based Investor a proud partner with
FEATURED POST
The case for factor investing in emerging markets
Most investors either ignore emerging markets or hand their money to active managers who underperform. Academic research points to a better approach: factor investing in emerging markets, targeting the company characteristics that have persistently driven higher returns.
Robin Powell
Search
Your fund family has outperformed? Yeah, right
Every year, some active fund families respond to the SPIVA scorecard with their own numbers — and those numbers always look better. They choose the start dates, benchmarks, and fee treatments that flatter them most. Here's how to see through it, and the one test that exposes what fund family marketing routinely hides.
Robin Powell
Mar 66 min read
The performance persistence myth: what new research tells us about the latest hot funds
Chasing last year’s top funds is seductive — and usually self-defeating. New evidence shows performance persistence is largely a mirage: most “winners” slip quickly, especially when markets get rough. Investors who keep costs low and own the market have far better odds of reaching their goals.
Robin Powell
Oct 20, 202511 min read
SPIVA persistence scorecard: why Robin Wigglesworth says the critics got it wrong
The SPIVA persistence scorecard has become a lightning rod for debate. Robin Wigglesworth shows how active managers’ critique collapses under scrutiny — and why persistence is the Achilles’ heel of their case.
Robin Powell
Sep 19, 20255 min read
SUBSCRIBE
Simply provide your email address to receive our regular update.
bottom of page